stock
Immuneering Corp
NASDAQ | IMRX
6.43
USD
$0.00
(0.00%
)At Close (As of Dec 3, 2025)
$431.97M
Market Cap
-
P/E Ratio
-1.69
EPS
$10.08
52 Week High
$1.10
52 Week Low
HEALTHCARE
Sector
IMRX Chart
Recent Chart
Price Action
IMRX Technicals
IMRX Earnings
Yearly Income Statement (As of Dec 31, 2024)
| Field | Value (USD) |
|---|---|
| Gross Profit | -$713K |
| Total Revenue | $0 |
| Cost Of Revenue | $713K |
| Costof Goods And Services Sold | $713K |
| Operating Income | -$64M |
| Selling General And Administrative | $16M |
| Research And Development | $48M |
| Operating Expenses | $64M |
| Investment Income Net | - |
| Net Interest Income | $2.6M |
| Interest Income | $2.6M |
| Interest Expense | - |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $385K |
| Income Before Tax | -$61M |
| Income Tax Expense | - |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | -$61M |
| Comprehensive Income Net Of Tax | - |
| Ebit | -$64M |
| Ebitda | -$64M |
| Net Income | -$61M |
Revenue & Profitability
Earnings Performance
IMRX Financials
yearly Balance Sheet (As of Dec 31, 2024)
| Field | Value (USD) |
|---|---|
| Total Assets | $53M |
| Total Current Assets | $40M |
| Cash And Cash Equivalents At Carrying Value | $36M |
| Cash And Short Term Investments | $36M |
| Inventory | - |
| Current Net Receivables | - |
| Total Non Current Assets | $13M |
| Property Plant Equipment | - |
| Accumulated Depreciation Amortization Ppe | - |
| Intangible Assets | $350K |
| Intangible Assets Excluding Goodwill | $350K |
| Goodwill | $6.7M |
| Investments | - |
| Long Term Investments | - |
| Short Term Investments | -$36B |
| Other Current Assets | $3.4M |
| Other Non Current Assets | - |
| Total Liabilities | $11M |
| Total Current Liabilities | $7.5M |
| Current Accounts Payable | $2M |
| Deferred Revenue | - |
| Current Debt | - |
| Short Term Debt | $338K |
| Total Non Current Liabilities | $3.8M |
| Capital Lease Obligations | $4.2M |
| Long Term Debt | - |
| Current Long Term Debt | - |
| Long Term Debt Noncurrent | - |
| Short Long Term Debt Total | $4.2M |
| Other Current Liabilities | $5.2M |
| Other Non Current Liabilities | - |
| Total Shareholder Equity | $41M |
| Treasury Stock | - |
| Retained Earnings | -$224M |
| Common Stock | $31K |
| Common Stock Shares Outstanding | $30M |
yearly Cash Flow (As of Dec 31, 2024)
| Field | Value (USD) |
|---|---|
| Operating Cashflow | -$55M |
| Payments For Operating Activities | - |
| Proceeds From Operating Activities | - |
| Change In Operating Liabilities | - |
| Change In Operating Assets | - |
| Depreciation Depletion And Amortization | $385K |
| Capital Expenditures | $85K |
| Change In Receivables | - |
| Change In Inventory | - |
| Profit Loss | - |
| Cashflow From Investment | $26M |
| Cashflow From Financing | $5.3M |
| Proceeds From Repayments Of Short Term Debt | - |
| Payments For Repurchase Of Common Stock | - |
| Payments For Repurchase Of Equity | - |
| Payments For Repurchase Of Preferred Stock | - |
| Dividend Payout | - |
| Dividend Payout Common Stock | - |
| Dividend Payout Preferred Stock | - |
| Proceeds From Issuance Of Common Stock | - |
| Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
| Proceeds From Issuance Of Preferred Stock | - |
| Proceeds From Repurchase Of Equity | - |
| Proceeds From Sale Of Treasury Stock | - |
| Change In Cash And Cash Equivalents | - |
| Change In Exchange Rate | - |
| Net Income | -$61M |
yearly Income Statement (As of Dec 31, 2024)
| Field | Value (USD) |
|---|---|
| Gross Profit | -$713K |
| Total Revenue | $0 |
| Cost Of Revenue | $713K |
| Costof Goods And Services Sold | $713K |
| Operating Income | -$64M |
| Selling General And Administrative | $16M |
| Research And Development | $48M |
| Operating Expenses | $64M |
| Investment Income Net | - |
| Net Interest Income | $2.6M |
| Interest Income | $2.6M |
| Interest Expense | - |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $385K |
| Income Before Tax | -$61M |
| Income Tax Expense | - |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | -$61M |
| Comprehensive Income Net Of Tax | - |
| Ebit | -$64M |
| Ebitda | -$64M |
| Net Income | -$61M |
IMRX News
IMRX Profile
Immuneering Corp Profile
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
None
LPTX +368.57%
$2.05
VRAX +54.64%
$0.60
PAVS -39.92%
$0.03
IXHL +14.75%
$0.45
VHAI 0.00%
$0.00
IRBT +60.25%
$3.12
TWOH
0.00%
$0.00
IPG -1.95%
$24.57
NVDA -0.84%
$179.93
AXDX -61.36%
$0.03
ONDS -2.81%
$7.84
JSPR -8.13%
$1.58
NIO -5.66%
$4.74
F -1.51%
$12.96
ADAP -15.14%
$0.05
TSLA +2.65%
$440.65
AMZN +0.23%
$234.42
SOND -23.45%
$0.12
BYND -4.55%
$1.23
INTC +0.18%
$43.55
ASST -1.93%
$1.01
RMBL +60.50%
$3.21
QCLS
+20.41%
$4.07
LNW -3.71%
$86.22
BTBT -0.44%
$2.24
ADD -25.47%
$0.05
RR +1.96%
$3.63
IREN +4.95%
$43.15
INHD -9.37%
$0.13
SRM +53.27%
$10.30
CAPR +360.53%
$29.29
PLUG +1.95%
$2.15
VALE +2.87%
$13.26
MRVL +3.97%
$96.58
BITF -2.65%
$3.01
BMNR
+3.44%
$33.01
BMNU
+6.13%
$7.79
WLGS -5.57%
$0.04
MTSR -0.35%
$70.50
PFE +2.12%
$25.68
NFLX +0.20%
$109.35
SOFI +0.16%
$29.55
AFMD -34.94%
$0.18
KITT +28.86%
$0.93
BBD -2.46%
$3.57
IMRN -12.06%
$1.53
PMAX +23.73%
$2.80
HTOO +14.85%
$4.02
GRYP -10.38%
$1.38
BTE -1.55%
$3.17
MODV -25.22%
$0.43
AAL +0.56%
$14.32
QBTS +2.12%
$22.97
TSLG -0.64%
$9.21
DNN +1.15%
$2.62
CMND -13.27%
$0.11
AAPL +0.06%
$286.39
CHR -6.96%
$0.04
ASBP -14.91%
$0.08
MSFT -2.02%
$480.09
PLTD -1.79%
$6.83
AMC -2.12%
$2.30
MARA +0.20%
$11.93
CIFR -0.68%
$17.52
AEO +14.17%
$23.78
AMD +0.01%
$215.26
PYPL -2.90%
$61.07
CLSK +0.84%
$13.82
GOOGL +1.42%
$320.32
ACHR +3.50%
$7.91
KDLY -2.95%
$0.48
CMG -0.29%
$34.14
WULF -4.04%
$13.64
SAND -6.04%
$12.12
PLTR +1.52%
$173.28
SHOT -74.37%
$0.39
GTLB -14.56%
$37.05
YGMZ -14.61%
$0.07
BTG +1.01%
$4.47
ZAPP -46.30%
$0.15
LYFT +3.73%
$22.24
KXIN +27.41%
$3.95
BMY +5.41%
$50.86
VIVK -13.43%
$0.09
MSTR -0.02%
$181.28
KEY -0.72%
$18.28
SU -1.91%
$43.94
HIMS -3.19%
$36.31
PINS +0.18%
$26.89
ON +2.08%
$51.48
PSTG -26.10%
$69.99
GPUS
-5.12%
$0.27
RGTI -0.10%
$23.85
M +0.15%
$22.74
NBIS -3.69%
$96.45
GOOG +1.57%
$321.01
CGC +2.25%
$1.13
AG -0.53%
$15.82
IONZ
+0.51%
$4.48
KVUE -0.41%
$16.79
LPTX +368.57%
$2.05
VRAX +54.64%
$0.60
PAVS -39.92%
$0.03
IXHL +14.75%
$0.45
VHAI 0.00%
$0.00
IRBT +60.25%
$3.12
TWOH
0.00%
$0.00
IPG -1.95%
$24.57
NVDA -0.84%
$179.93
AXDX -61.36%
$0.03
ONDS -2.81%
$7.84
JSPR -8.13%
$1.58
NIO -5.66%
$4.74
F -1.51%
$12.96
ADAP -15.14%
$0.05
TSLA +2.65%
$440.65
AMZN +0.23%
$234.42
SOND -23.45%
$0.12
BYND -4.55%
$1.23
INTC +0.18%
$43.55
ASST -1.93%
$1.01
RMBL +60.50%
$3.21
QCLS
+20.41%
$4.07
LNW -3.71%
$86.22
BTBT -0.44%
$2.24
ADD -25.47%
$0.05
RR +1.96%
$3.63
IREN +4.95%
$43.15
INHD -9.37%
$0.13
SRM +53.27%
$10.30
CAPR +360.53%
$29.29
PLUG +1.95%
$2.15
VALE +2.87%
$13.26
MRVL +3.97%
$96.58
BITF -2.65%
$3.01
BMNR
+3.44%
$33.01
BMNU
+6.13%
$7.79
WLGS -5.57%
$0.04
MTSR -0.35%
$70.50
PFE +2.12%
$25.68
NFLX +0.20%
$109.35
SOFI +0.16%
$29.55
AFMD -34.94%
$0.18
KITT +28.86%
$0.93
BBD -2.46%
$3.57
IMRN -12.06%
$1.53
PMAX +23.73%
$2.80
HTOO +14.85%
$4.02
GRYP -10.38%
$1.38
BTE -1.55%
$3.17
MODV -25.22%
$0.43
AAL +0.56%
$14.32
QBTS +2.12%
$22.97
TSLG -0.64%
$9.21
DNN +1.15%
$2.62
CMND -13.27%
$0.11
AAPL +0.06%
$286.39
CHR -6.96%
$0.04
ASBP -14.91%
$0.08
MSFT -2.02%
$480.09
PLTD -1.79%
$6.83
AMC -2.12%
$2.30
MARA +0.20%
$11.93
CIFR -0.68%
$17.52
AEO +14.17%
$23.78
AMD +0.01%
$215.26
PYPL -2.90%
$61.07
CLSK +0.84%
$13.82
GOOGL +1.42%
$320.32
ACHR +3.50%
$7.91
KDLY -2.95%
$0.48
CMG -0.29%
$34.14
WULF -4.04%
$13.64
SAND -6.04%
$12.12
PLTR +1.52%
$173.28
SHOT -74.37%
$0.39
GTLB -14.56%
$37.05
YGMZ -14.61%
$0.07
BTG +1.01%
$4.47
ZAPP -46.30%
$0.15
LYFT +3.73%
$22.24
KXIN +27.41%
$3.95
BMY +5.41%
$50.86
VIVK -13.43%
$0.09
MSTR -0.02%
$181.28
KEY -0.72%
$18.28
SU -1.91%
$43.94
HIMS -3.19%
$36.31
PINS +0.18%
$26.89
ON +2.08%
$51.48
PSTG -26.10%
$69.99
GPUS
-5.12%
$0.27
RGTI -0.10%
$23.85
M +0.15%
$22.74
NBIS -3.69%
$96.45
GOOG +1.57%
$321.01
CGC +2.25%
$1.13
AG -0.53%
$15.82
IONZ
+0.51%
$4.48
KVUE -0.41%
$16.79